Biomarkers of early respiratory effects in smoking adolescents

European Respiratory Journal

Volumn 38, Issue 6, 2011, Pages 1287-1293

  Van Miert, E ^a   Sardella, A ^a   Bernard, A ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Adolescents; Biomarkers; Cigarette smoke; Clara cell protein 16; Nasal lavage fluid; Nitric oxide

Indexed keywords

CLARA CELL PROTEIN; CLARA CELL PROTEIN 16; NITRIC OXIDE; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ADOLESCENT; ADOLESCENT SMOKING; AGE; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BIRTH WEIGHT; BODY MASS; COMMON COLD; CONTROLLED STUDY; COUGHING; CROSS-SECTIONAL STUDY; FEMALE; GENDER; HAY FEVER; HUMAN; LOWER RESPIRATORY TRACT INFECTION; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; WHEEZING;

ADOLESCENT; BIOLOGICAL MARKERS; BREATH TESTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LUNG; MALE; NASAL LAVAGE FLUID; NITRIC OXIDE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RESPIRATORY TRACT DISEASES; SMOKING; TOBACCO SMOKE POLLUTION; UTEROGLOBIN;

EID: 82555173003     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00000911     Document Type: Article

References (33)

1. van Beek EJ, Hoffman EA. Functional imaging: CT and MRI. Clin Chest Med 2008; 29: 195-216. (Pubitemid 351220915)
2. Kharitonov SA, Barnes PJ. Biomarkers of some pulmonary diseases in exhaled breath. Biomarkers 2002; 7: 1-32. (Pubitemid 34097607)
3. Quirce S, Lemière C, Blay F, et al. Noninvasive methods for assessment of airway inflammation in occupational settings. Allergy 2010; 65: 445-458.
4. Hermans C, Bernard A. Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med 1999; 159: 646-678.
5. Irvin CG. The nose: a window into the asthmatic lung? Clin Exp Allergy 2010; 40: 839-840.
6. Kharitonov SA, Barnes PJ. Clinical aspects of exhaled nitric oxide. Eur Respir J 2000; 16: 781-792.
7. Sin DD, Leung R, Gan WQ, et al. Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study. BMC Pulm Med 2007; 7: 13.
8. Braido F, Riccio AM, Guerra L, et al. Clara cell 16 protein in COPD sputum: a marker of small airways damage? Respir Med 2007; 101: 2119-2124. (Pubitemid 47324246)
9. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, Centers for Disease Control and Prevention, 2004.
10. ASPECT (Analysis of the Science and Policy for European Control of Tobacco) Consortium. Tobacco or Health in the European Union: Past, Present and Future. Luxembourg, European Commission, 2004. http://ec.europa.eu/health/ph- determinants/life-style/Tobacco/Documents/tobacco-fr-en.pdf
11. Kjaergaard T, Cvancarova M, Steinsvaag SK. Smoker's nose: structural and functional characteristics. Laryngoscope 2010; 120: 1475-1480.
12. Robin M, Dong P, Hermans C, et al. Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects. Eur Respir J 2002; 20: 1152-1161. (Pubitemid 35331872)
13. Dell Ommo M, Hermans C, Muzi G, et al. Serum Clara cell protein (CC16) in healthy young smokers. Biomarkers 2000; 5: 158-164. (Pubitemid 30167291)
14. Shijubo N, Itoh Y, Yamaguchi T, et al. Serum and BAL Clara cell 10 kDa protein (CC10) levels and CC10-positive bronchiolar cells are decreased in smokers. Eur Respir J 1997; 10: 1108-1114. (Pubitemid 27201817)
15. Kharitonov SA, Robbins RA, Yates D, et al. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 1995; 152: 609-612.
16. Gabriele C, Asgarali R, Jaddoe VW, et al. Smoke exposure, airway symptoms and exhaled nitric oxide in infants: the Generation R study. Eur Respir J 2008; 32: 307-313.
17. Lederer DJ, Enright PL, Kawut SM, et al. Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study. Am J Respir Crit Care Med 2009; 180: 407-414.
18. Bernard A, Carbonnelle S, Dumont X, et al. Infant swimming practice, pulmonary epithelium integrity, and the risk of allergic and respiratory diseases later in childhood. Paediatrics 2007; 119: 1095-1103. (Pubitemid 46871264)
19. American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-930.
20. Hermans C, Bernard A. Pneumoproteinaemia: a new perspective in the assessment of lung disorders. Eur Respir J 1998; 11: 801-803. (Pubitemid 28231269)
21. Cavaliere F, Schiavello R, Masieri S, et al. Urea to calculate the dilution of nasal secretum collected by lavage. Acta Otorhinolaryngol Belg 1986; 40: 542-547.
22. Kaulbach HC, White MV, Igarashi Y, et al. Estimation of nasal epithelial lining fluid using urea as a marker. J Allergy Clin Immunol 1993; 92: 457-465. (Pubitemid 24088698)
23. Aragon TJ. Medical Epidemiology. "epitools" - R package for epidemiologic data and graphics. 2008. www.medepi.com/epitools
24. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Institute for Statistics and Mathematics, 2008. www.r-project.org
25. Wickham H. ggplot2: elegant graphics for data analysis. New York, Springer, 2009. http://had.co.nz/ggplot2/book
26. Moravcsik MJ. Citation context classification of a citation classic concerning citation context classification. Soc Stud Sci 1988; 18: 515-521.
27. Broeckaert F, Clippe A, Knoops B, et al. Clara cell secretory protein (CC16): features as a peripheral lung biomarker. Ann NY Acad Sci 2000; 923: 68-77. (Pubitemid 32050206)
28. Honda Y, Takahashi H, Kuroki Y, et al. Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest 1996; 109: 1006-1009. (Pubitemid 26113645)
29. Lovasi GS, Diez Roux AV, Hoffman EA, et al. Association of environmental tobacco smoke exposure in childhood with early emphysema in adulthood among nonsmokers: the MESA-lung study. Am J Epidemiol 2010; 171: 54-62.
30. Barnes PJ, Belvisi MG. Nitric oxide and lung disease. Thorax 1993;48: 1034-1043. (Pubitemid 23319631)
31. Nadel JA. Role of epidermal growth factor receptor activation in regulating mucin synthesis. Respir Res 2001; 2: 85-89. (Pubitemid 34187912)
32. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD). Am J Respir Crit Care Med 2001; 163: 1256-1276. (Pubitemid 32378468)
33. Hadar T, Yaniv E, Shvili Y, et al. Histopathological changes of the nasal mucosa induced by smoking. Inhal Toxicol 2009; 21: 1119-1122.